HopeStage
Back to all studies
RecruitingNCT07478796

Blood-level-guided SSRI treatment for depression in young people and adults

About this titleRead the official source — NCT07478796
Medication studyAges 12+Poland
The study in practice

Understand this study

Who could participate?

Listed age limits: from 12 years.

Listed locations
PoznanSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: April 3, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
180
Sponsor
Poznan University of Medical Sciences
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Poland
Age range
Over 12 Years
Official registry ID
NCT07478796
Official title
Show the full official title

Therapeutic Drug Monitoring-Guided Treatment With Sertraline, or Escitalopram in Hospitalized Adults and Children

Recruitment & locations

Currently recruiting

Poznan

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Poznan University of Medical Sciences, a university.

Does this study involve medication?

Yes. The study involves medication, including Fluoxetine, Escitalopram and Sertralin.

Who can participate?

Listed age limits: from 12 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies